Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Denmark / NCT06771102
Recruiting Not applicable

Performance Characteristics and Technical Outcomes of Single-use Gastroscopes Used Bedside Versus Reusable Gastroscopes Used in the Endoscopy Unit Evaluated in Subacute Patients

NCT06771102 · tracked via the Priya Life Science Denmark tracker
Sponsor
Zealand University Hospital
Phase
Not applicable
Started
2025-01-13
Last updated
2026-07-16

Condition(s) studied

Upper Gastrointestinal Disorder

Investigational drug(s) / intervention(s)

Ambu aScope GastroDiagnostic gastroscopes, Olympus

Ambu aScope Gastro: CE-marked single-use gastroscopes from Ambu are used in the single-use group.

Diagnostic gastroscopes, Olympus: Reusable gastroscopes from Olympus are used in the reusable group.

Study summary

The aim of this study is to investigate whether single-use gastroscopes used bedside can reduce the time from indication to procedure compared with re-usable gastroscopes used at the endoscopy unit in patients referred to a subacute gastroscopy.

Participants in the first period will be scheduled for gastroscopy with a re-usable gastroscope in the endoscopy unit, whereas participants during the second period will have a gastroscopy performed at the ward (bed-side) with a single-use gastroscope.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients of any gender, 18 years of age or older admitted to the acute section of the surgical department (Kir2) at Zealand University Hospital referred to early EGD without general anesthesia. Exclusion Criteria: * ASA-score of 4 or higher * Unstable patient * Suspicion of ventricular retention * Suspicion of active bleeders * Need for expert endoscopist to perform the procedure, e.g. stenting * Patients \< 18 years of age

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zealand University Hospital Køge Denmark Recruiting

More Zealand University Hospital trials in Denmark

Performance Characteristics and Technical Outcomes of Single-use vs. Reusable Gastroscopes Evaluated in the OR Recruiting
Sarcopenia and Cachexia in Patients With Lung Cancer Enrolling by invitation
Sex, Psychopharmacology, and Diabetes Recruiting
Virtual Reality to Reduce Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy Recruiting
Study on the Effect of 40 Hz Non-Invasive Light Therapy System Recruiting

Other trials for the same condition

Performance Characteristics and Technical Outcomes of Single-use vs. Reusable Gastroscopes Evaluated in the OR Recruiting
Endoscopists' Perspectives on the Use of Single-Use Gastroscopes in Elective and Subacute Patients in the Endoscopy Unit Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06771102 on ClinicalTrials.gov ↗ ← All trials in Denmark